Drugs & Targets Cleave Biosciences’s CB-5083 receives FDA orphan drug designation July 17, 2015Vol.41 No.28
Drugs & Targets FDA grants orphan drug designation to ImMucin in multiple myeloma July 17, 2015Vol.41 No.28
